{"bill":{"bill_id":1379013,"change_hash":"b7601c71b95536769b60229b2564d534","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB4702\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/4702\/all-info","completed":0,"status":1,"status_date":"2020-09-24","progress":[{"date":"2020-09-24","event":1},{"date":"2020-09-24","event":9}],"state":"US","state_id":52,"bill_number":"SB4702","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"IMPROVE Addiction Care Act Improving Medicaid Programs' Response to Overdose Victims and Enhancing Addiction Care Act","description":"Establishes additional requirements for state Medicaid drug-use review programs with respect to individuals who experience opioid-related overdoses. Specifically, programs must include protocols that (1) connect individuals who have experienced an opioid-related overdose within the last five years to appropriate treatment; (2) notify providers who prescribe opioids about subsequent fatal overdoses; (3) ensure providers are notified about an individual's history of opioid-use disorder, overdoses, or poisonings; and (4) educate providers about proper prescribing practices for these individuals.","pending_committee_id":2326,"committee":{"committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"},"referrals":[{"date":"2020-09-24","committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"}],"history":[{"date":"2020-09-24","action":"Read twice and referred to the Committee on Finance.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":11905,"person_hash":"j65ej594","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"Pat Toomey","first_name":"Pat","middle_name":"","last_name":"Toomey","suffix":"","nickname":"","district":"SD-PA","ftm_eid":4944091,"votesmart_id":24096,"opensecrets_id":"N00001489","knowwho_pid":159045,"ballotpedia":"Pat_Toomey","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":9625,"person_hash":"7pac6cxl","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Joe Manchin","first_name":"Joe","middle_name":"","last_name":"Manchin","suffix":"III","nickname":"","district":"SD-WV","ftm_eid":7573477,"votesmart_id":7547,"opensecrets_id":"N00032838","knowwho_pid":219013,"ballotpedia":"Joe_Manchin_III","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":1,"type":"Same As","sast_bill_number":"HB8388","sast_bill_id":1378963}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13307,"subject_name":"Drug, alcohol, tobacco use"},{"subject_id":13208,"subject_name":"Health care quality"},{"subject_id":13210,"subject_name":"Health information and medical records"},{"subject_id":13239,"subject_name":"Medicaid"},{"subject_id":13490,"subject_name":"Prescription drugs"},{"subject_id":13285,"subject_name":"State and local government operations"}],"texts":[{"doc_id":2213084,"date":"2020-10-21","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB4702\/id\/2213084","state_link":"https:\/\/www.congress.gov\/116\/bills\/s4702\/BILLS-116s4702is.pdf","text_size":295156,"text_hash":"488c1938491e2f40cb99f6b92ee02a55"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}